Core Viewpoint - The company has approved a share repurchase plan, intending to buy back shares using its own funds within a specified price range and timeframe [1][2]. Summary by Sections Share Repurchase Plan - The company plans to repurchase shares with a budget between RMB 15 million and RMB 30 million, with a maximum repurchase price set at RMB 44 per share [1]. - Following the annual equity distribution on May 22, 2025, the maximum repurchase price was adjusted to RMB 43.77 per share [2]. Progress of Share Repurchase - As of July 31, 2025, the company has not yet repurchased any shares, with the total repurchased shares standing at 0, which is 0% of the total share capital [2]. Compliance and Regulations - The share repurchase plan complies with relevant laws, regulations, and the company's own guidelines [3][4]. - The company has not engaged in share repurchase during periods that could significantly impact the trading price of its securities [4]. - The repurchase will be conducted through centralized bidding, adhering to specific trading restrictions [5]. Future Actions - The company will continue to implement the repurchase plan based on market conditions and will fulfill its information disclosure obligations as required by law [5].
上海优宁维生物科技股份有限公司关于回购公司股份的进展公告